Clinical trial
Deep Vein Thrombosis (DVT) Prevention in Total Hip Arthroplasty: Continuous…
NCT00358735 · Medical Compression Systems, Industry · Completed
Key facts
| NCT number | NCT00358735 |
|---|---|
| Title | Deep Vein Thrombosis (DVT) Prevention in Total Hip Arthroplasty: Continuous Enhanced Circulation Therapy (CECT) Versus Low Molecular Weight Heparin (LMWH) |
| Official title | Deep Vein Thrombosis (DVT) Prevention in Total Hip Arthroplasty (THA): Continuous Enhanced Circulation Therapy (CECT) Versus Low Molecular Weight Heparin (LMWH) |
| Acronym | SAFE |
| Lead sponsor | Medical Compression Systems, Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Deep Vein Thrombosis of Lower Limb, Pulmonary Embolism (PE), Bleeding |
| Intervention type | Device, Drug |
| Interventions | ActiveCare CECT device, Enoxaparin |
| Enrollment | 411 |
| Start date | Jun 1, 2006 |
| Primary completion | Sep 1, 2008 |
| Completion | Dec 1, 2008 |
| First posted | Aug 1, 2006 |
| Last update posted | Oct 30, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: